DE602006018367D1 - Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzen - Google Patents
Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzenInfo
- Publication number
- DE602006018367D1 DE602006018367D1 DE602006018367T DE602006018367T DE602006018367D1 DE 602006018367 D1 DE602006018367 D1 DE 602006018367D1 DE 602006018367 T DE602006018367 T DE 602006018367T DE 602006018367 T DE602006018367 T DE 602006018367T DE 602006018367 D1 DE602006018367 D1 DE 602006018367D1
- Authority
- DE
- Germany
- Prior art keywords
- diseases
- pain
- organic solvent
- inflammatory
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000031888 Mycoses Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 206010065390 Inflammatory pain Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 239000003960 organic solvent Substances 0.000 abstract 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 abstract 2
- 229930182817 methionine Natural products 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Rheumatology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/010665 WO2007108807A1 (en) | 2006-03-20 | 2006-03-20 | Composition for treating bacterial, viral, fungal diseases, inflammation and pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006018367D1 true DE602006018367D1 (de) | 2010-12-30 |
Family
ID=38522752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006018367T Active DE602006018367D1 (de) | 2006-03-20 | 2006-03-20 | Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1996014B1 (de) |
| JP (1) | JP5086331B2 (de) |
| CN (1) | CN101400255B (de) |
| AT (1) | ATE488137T1 (de) |
| AU (1) | AU2006340367B2 (de) |
| BR (1) | BRPI0621416A2 (de) |
| CA (1) | CA2645881A1 (de) |
| DE (1) | DE602006018367D1 (de) |
| MX (1) | MX2008011934A (de) |
| WO (1) | WO2007108807A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5587969B2 (ja) * | 2009-03-18 | 2014-09-10 | オラテック インダストリーズ リミティド ライアビリティ カンパニー | 炎症及び疼痛の処置用の化合物 |
| EP2651407B1 (de) | 2010-12-15 | 2016-12-21 | Olatec Industries LLC | 3-methansulfonylpropionitril zur behandlung von entzündungen und schmerzen |
| AU2013271836B2 (en) * | 2012-06-05 | 2018-03-01 | Olatec Therapeutics Llc | Method for treating skin inflammatory diseases |
| CN109453194A (zh) * | 2018-11-21 | 2019-03-12 | 四川水喜宝科技发展有限公司 | 一种物理灭菌活化养目的中药组合物及组合套装 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2106389B (en) * | 1981-07-16 | 1985-07-17 | Nat Res Dev | The inhibition of growth in fungi |
| US5053429A (en) * | 1988-04-08 | 1991-10-01 | The Lithox Corporation, Inc. | Treating inflammatory pain with methionine |
| US5084482A (en) * | 1990-04-10 | 1992-01-28 | The Lithox Corporation | Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds |
| WO2004045539A2 (en) * | 2002-11-15 | 2004-06-03 | Regents Of The University Of California | Anti-microbial agents derived from methionine sulfoximine analogues |
-
2006
- 2006-03-20 BR BRPI0621416-9A patent/BRPI0621416A2/pt not_active Application Discontinuation
- 2006-03-20 DE DE602006018367T patent/DE602006018367D1/de active Active
- 2006-03-20 AU AU2006340367A patent/AU2006340367B2/en not_active Ceased
- 2006-03-20 MX MX2008011934A patent/MX2008011934A/es not_active Application Discontinuation
- 2006-03-20 CA CA002645881A patent/CA2645881A1/en not_active Abandoned
- 2006-03-20 CN CN2006800539294A patent/CN101400255B/zh not_active Expired - Fee Related
- 2006-03-20 WO PCT/US2006/010665 patent/WO2007108807A1/en active Application Filing
- 2006-03-20 JP JP2009501394A patent/JP5086331B2/ja not_active Expired - Fee Related
- 2006-03-20 EP EP06739456A patent/EP1996014B1/de not_active Not-in-force
- 2006-03-20 AT AT06739456T patent/ATE488137T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006340367A1 (en) | 2007-09-27 |
| JP5086331B2 (ja) | 2012-11-28 |
| BRPI0621416A2 (pt) | 2011-12-06 |
| CA2645881A1 (en) | 2007-09-27 |
| CN101400255B (zh) | 2012-07-04 |
| EP1996014B1 (de) | 2010-11-17 |
| ATE488137T1 (de) | 2010-12-15 |
| EP1996014A1 (de) | 2008-12-03 |
| JP2009534305A (ja) | 2009-09-24 |
| CN101400255A (zh) | 2009-04-01 |
| WO2007108807A1 (en) | 2007-09-27 |
| EP1996014A4 (de) | 2009-11-11 |
| MX2008011934A (es) | 2008-11-27 |
| AU2006340367B2 (en) | 2012-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
| EA201100299A1 (ru) | Органические соединения | |
| EA201892339A3 (ru) | Несиалированный выделенный полипептид, способ получения указанного полипептида и фармацевтическая композиция для лечения воспалительного заболевания | |
| EA201491028A1 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
| EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
| EA201590073A1 (ru) | Противовирусные соединения | |
| WO2007075598A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
| WO2007095050A3 (en) | N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase | |
| EA201290836A1 (ru) | Связанные бис-арильные арилтриазолоны и их применение | |
| ATE411280T1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| WO2007070779A3 (en) | A method to treat premature ejaculation in humans | |
| EA201270575A1 (ru) | Соединения | |
| EA201390826A1 (ru) | ПИРИМИДИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ИЛИ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ Lp-PLA | |
| EA200501399A1 (ru) | Производные бензопирана, которые могут использоваться при лечении воспалительных заболеваний | |
| EA200901289A1 (ru) | Композиции и способы для противовосполительного лечения | |
| GEP20115293B (en) | Isolated extract of walnuts, process for its obtaining and its use | |
| EA201101579A1 (ru) | Имидазо[1,2-а]пиридин-2-ил-фенил производные для лечения рака | |
| CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| UA107562C2 (uk) | Спосіб лікування псоріазу | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
| DE602006018367D1 (de) | Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzen | |
| MA32945B1 (fr) | Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique |